# Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Eczema/Dermatitis and Dermal Pruritus (MK-4117-202)

> **NCT01916980** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 94 (actual)

## Conditions studied

- Eczema
- Dermatitis
- Dermal Pruritus

## Interventions

- **DRUG:** Desloratadine 5 mg

## Key facts

- **NCT ID:** NCT01916980
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08-27
- **Primary completion:** 2014-03-08
- **Final completion:** 2014-03-22
- **Target enrollment:** 94 (ACTUAL)
- **Last updated:** 2024-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01916980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01916980, "Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Eczema/Dermatitis and Dermal Pruritus (MK-4117-202)". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT01916980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*